Clinical Study
Hypertension Control and Cardiometabolic Risk: A Regional Perspective
Table 7
Blood pressure and HDL-Cholesterol (mmol/L ± SD, adjusted for age, gender, and diabetes).
| | Total
() | Northern Europe
() | Southern Europe
() | North America
() | Middle East
() | Asia
() | value |
| | SBP (mmHg) | | | | | | | | | <120 | 1.3 (0.025) | 1.4 (0.051) | 1.2 (0.044) | 1.4 (0.065) | 1.1 (0.135) | 1.3 (0.053) | 0.0498 | | 120–139 | 1.3 (0.008) | 1.4 (0.015) | 1.3 (0.012) | 1.3 (0.024) | 1.1 (0.054) | 1.3 (0.018) | <0.0001 | | 140–159 | 1.3 (0.007) | 1.5 (0.011) | 1.3 (0.010) | 1.3 (0.024) | 1.2 (0.034) | 1.3 (0.017) | <0.0001 | | 160–179 | 1.3 (0.009) | 1.4 (0.014) | 1.3 (0.014) | 1.3 (0.035) | 1.1 (0.035) | 1.3 (0.025) | <0.0001 | | ≥180 | 1.3 (0.016) | 1.5 (0.025) | 1.2 (0.026) | 1.3 (0.070) | 1.0 (0.059) | 1.3 (0.045) | <0.0001 | | value | 0.3309 | 0.0558 | 0.1317 | 0.3366 | 0.6608 | 0.7711 | | | DBP (mmHg) | | | | | | | | | <90 | 1.3 (0.005) | 1.4 (0.010) | 1.3 (0.009) | 1.3 (0.017) | 1.2 (0.038) | 1.3 (0.014) | <0.0001 | | 90–99 | 1.3 (0.007) | 1.4 (0.012) | 1.3 (0.011) | 1.3 (0.033) | 1.2 (0.033) | 1.3 (0.020) | <0.0001 | | 100–109 | 1.3 (0.011) | 1.4 (0.016) | 1.2 (0.014) | 1.3 (0.047) | 1.1 (0.034) | 1.2 (0.024) | <0.0001 | | ≥110 | 1.3 (0.033) | 1.6 (0.057) | 1.2 (0.052) | 1.4 (0.208) | 1.0 (0.114) | 1.2 (0.102) | <0.0001 | | value | 0.0222 | 0.0013 | 0.0904 | 0.7721 | 0.0188 | 0.6265 | | | RR (mmHg) | | | | | | | | | uncontrolled* | 1.3 (0.006) | 1.5 (0.008) | 1.3 (0.008) | 1.3 (0.019) | 1.1 (0.022) | 1.3 (0.013) | <0.0001 | | controlled** | 1.3 (0.006) | 1.4 (0.016) | 1.3 (0.013) | 1.3 (0.023) | 1.1 (0.054) | 1.3 (0.019) | <0.0001 | | value | 0.1340 | 0.0916 | 0.1632 | 0.9361 | 0.8361 | 0.8030 | |
|
|
*SBP/DBP ≥140/90 in non-diabetic and ≥130/80 in diabetic patients, **<140/90 in non-diabetic and <130/80 in diabetic patients.
|
